Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 132866-11-6 | Product Number: L0282
Lercanidipine Hydrochloride
Purity: >98.0%(T)(HPLC)
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | L0282 |
Purity / Analysis Method
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__3__6H__4__1N__3O__6·HCl = 648.20 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Light Sensitive,Heat Sensitive |
Packaging and Container
|
1G-Glass Bottle with Plastic Insert (View image), 200MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 132866-11-6 |
Related CAS RN
|
100427-26-7 |
| Reaxys Registry Number | 7406263 |
| PubChem Substance ID | 253660808 |
| Merck Index (14) | 5446 |
| MDL Number | MFCD07773089 |
| Appearance | Light orange to Yellow to Green powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting Point | 195 °C(dec.) |
| Solubility (soluble in) | Methanol |
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
| HS Number | 2933399999 |
Reference
- Lercanidipine Synergistically Enhances Bortezomib Cytotoxicity in Cancer Cells via Enhanced Endoplasmic Reticulum Stress and Mitochondrial Ca2+ Overload
- Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine
- L. Guarneri, P. Angelico, M. Ibba, E. Poggesi, C, Taddei, A. Leonardi, R. Testa, Arzneim.-Forsch. 1996, 46, 15.
- Lercanidipine (Rec 15/2375): a novel 1,4-dihydropyridine calcium antagonist for hypertension (a review)
- Development and evaluation of buccoadhesive controlled release tablets of lercanidipine
- Oral self emulsifying powder of lercanidipine hydrochloride: Formulation and evaluation
- Determination of lercanidipine hydrochloride and its impurities in tablets
References
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.